Development

>

Latest News

Human urinary system kidneys with bladder anatomy on doctor hands. Treatment of urinary tract infections, urinary incontinence or urinary retention. Urology concept. | Image Credit: © Orawan - stock.adobe.com
Iterum Launches UTI Drug, First Oral Penem Antibiotic Commercially Available in US

August 20th 2025

Orlynvah is the first new, branded product for the treatment of uncomplicated UTIs to be introduced in the US in more than 25 years.

Lung cancer, 3D illustration and photo under microscope. Histopathology light micrograph of small cell lung cancer | Image Credit: © Dr_Microbe - © Dr_Microbe - stock.adobe.com
Merck and Daiichi Sankyo’s I-DXd Earns FDA Breakthrough Therapy Status in Small Cell Lung Cancer

August 19th 2025

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
FDA Grants Breakthrough Therapy Designation to Bispecific ADC for EGFR-Mutant Lung Cancer

August 18th 2025

Indianapolis, Indiana, USA - June 13, 2024: The exterior of the Eli Lilly and Company headquarters. Eli Lilly and Company is an American pharmaceutical company. | Image Credit: © Katherine Welles - stock.adobe.com
Lilly Statement: MFN Pricing Targeted for September 1, Pushback on Pharma Tariffs

August 18th 2025

Warsaw, Poland. 31 July 2024. Wola business district in the city center with office centers and modern buildings. Urban landscape. Company signboard Sanofi. | Image Credit: © Grand Warszawski - stock.adobe.com
MHRA Approves Sanofi’s Teplizumab to Delay Onset of Stage III T1D

August 14th 2025

Research into Cold Cancers Heating Up

Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.

Research into Cold Cancers Heating Up; Image: catalin - stock.adobe.com
<1
...
5758596061
© 2025 MJH Life Sciences

All rights reserved.